𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Combined therapy with ganciclovir and foscarnet for cytomegalovirus polyradiculomyelitis in patients with AIDS

✍ Scribed by Marina Karmochkine; Jean-Michel Molina; Catherine Scieux; Yves Welker; Frédéric Morinet; Jean-Marie Decazes; Philippe Lagrange; Laurence Schnell; Jacques Modai

Book ID
115684602
Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
304 KB
Volume
97
Category
Article
ISSN
1555-7162

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Foscarnet and ganciclovir pharmacokineti
Foscarnet and ganciclovir pharmacokinetics during concomitant or alternating maintenance therapy for AIDS-related cytomegalovirus retinitis*
✍ Aweeka, Francesca T.; Gambertoglio, John G.; Kramer, Françoise; van der Horst, 📂 Article 📅 1995 🏛 Nature Publishing Group 🌐 English ⚖ 849 KB

Introdwtiun: The we of foscarnet and ganciclovir as a combination treatment for cytomegalovirus retinitis is increasing because of limitations associated with single agent therapy. Methal: The pharmacokinetics of foscarnet and ganciclovir were determined in 13 patients receiving either concomitant t

Resistance to combined ganciclovir and f
Resistance to combined ganciclovir and foscarnet therapy in a liver transplant recipient with possible dual-strain cytomegalovirus coinfection
✍ John Rodriguez; Katherine Casper; Gregory Smallwood; Andrei Stieber; Carlos Faso 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB

We present a case report of a cytomegalovirus (CMV)-seronegative, 58-year-old male who received a CMV-seropositive donor liver transplant without CMV prophylaxis. On postoperative day 30, the patient developed primary CMV disease that responded to ganciclovir. On postoperative day 114, however, he w

Treatment of cytomegalovirus pneumonitis
Treatment of cytomegalovirus pneumonitis with foscarnet (trisodium phosphonoformate) in patients with AIDS
✍ C. Farthing; M. G. Anderson; M. E. Ellis; B. G. Gazzard; A. C. Chanas 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 319 KB

Foscarnet was administered to eight AIDS patients for suspected cytomegalovirus (CMV) pneumonitis as a continuous intravenous infusion for a minimum of 8 days. All the patients improved, three showing complete resolution of symptoms. Evidence of CMV infection from bronchoalveolar lavage samples was